Regulus Therapeutics
Moh Ahmadian is currently serving as the VP of Chemistry & Pharmaceutical Development at Regulus Therapeutics. With previous experience at Kinovate Life Sciences and Nitto Denko Technical Corp., Moh has extensive expertise in RNA synthesis, lipid-siRNA complex formation, and siRNA purification. Moh holds a Ph.D. in Medicinal Chemistry from Purdue University and has a Master of Science degree in Organic Chemistry from Ball State University.
This person is not in any offices
Regulus Therapeutics
1 followers
Regulus Therapeutics Inc. (Nasdaq:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs.